Acquisition by Gibney Anthony S of 6710 shares of Clearside Biomedical at 1.25 subject to Rule 16b-3

CLSD Stock  USD 1.05  0.02  1.87%   
About 51% of Clearside Biomedical's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Clearside Biomedical stock suggests that some investors are interested at this time. The current market sentiment, together with Clearside Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearside Biomedical stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Clearside Biomedical Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 6710 common stock at 1.25 of Clearside Biomedical by Gibney Anthony S on 17th of April 2024. This event was filed by Clearside Biomedical with SEC on 2024-04-17. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Clearside Biomedical's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Clearside Biomedical's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Clearside Biomedical Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Clearside Biomedical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Clearside Biomedical Fundamental Analysis

We analyze Clearside Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearside Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearside Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Clearside Biomedical is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Clearside Biomedical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearside Biomedical stock to make a market-neutral strategy. Peer analysis of Clearside Biomedical could also be used in its relative valuation, which is a method of valuing Clearside Biomedical by comparing valuation metrics with similar companies.

Peers

Clearside Biomedical Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
TNYATenaya Therapeutics   11.15   
0%
81.0%
LYRALyra Therapeutics   10.53   
0%
76.0%
CCCCC4 Therapeutics   8.59   
0%
62.0%
GBIOGeneration Bio   6.29   
0%
45.0%
OCULOcular Therapeutix   3.18   
0%
23.0%
EWTXEdgewise Therapeutics   2.48   
0%
18.0%
DSGNDesign Therapeutics   0.50   
0%
3.0%
NUVBNuvation Bio   0.35   
0%
2.0%
INZYInozyme Pharma   0.37   
2.0%
0%
ORICOric Pharmaceuticals   0.70   
5.0%
0%
KRONKronos Bio   1.04   
7.0%
0%
EPIXESSA Pharma   1.10   
8.0%
0%
ERASErasca   2.05   
14.0%
0%
DRTSAlpha Tau   2.10   
15.0%
0%
INBXInhibrx   2.37   
17.0%
0%
NXTCNextCure   2.50   
18.0%
0%
SNSESensei Biotherapeutics   3.57   
26.0%
0%

Complementary Tools for Clearside Stock analysis

When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges